peter attia bpc-157 BPC157 and Anti-Aging Insights with peter attia bpc 157 Peter

Originally engineered at Washington State University by the Harding lab and later licensed to M3 Biotechnology, Dihexa retains the angiotensin IV pharmacophore for AT4 receptor binding while incorporating N-hexanoyl and aminohexanoic acid modifications that confer metabolic stability and lipophilic BBB penetration

However, the absence of formal clinical trials means long-term safety cannot be guaranteed

Sleep deeper & release serotonin

Use as directed and consult a healthcare provider if unsure

Its particularly effective at thickening individual strands and increasing overall density

doi: 10.1016/j.biocel.2020.105802